196 related articles for article (PubMed ID: 16352338)
1. Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
J Infect; 2006 Sep; 53(3):190-8. PubMed ID: 16352338
[TBL] [Abstract][Full Text] [Related]
2. Risk of bacteraemia and mortality in patients with haematological malignancies.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
Clin Microbiol Infect; 2006 Mar; 12(3):217-23. PubMed ID: 16451407
[TBL] [Abstract][Full Text] [Related]
3. Short-term mortality of bacteraemia in elderly patients with haematological malignancies.
Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Rothman KJ; Sørensen HT
Br J Haematol; 2006 Jan; 132(1):25-31. PubMed ID: 16371016
[TBL] [Abstract][Full Text] [Related]
4. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
Todeschini G; Tecchio C; Borghero C; D'Emilio A; Pegoraro E; de Lalla F; Benedetti P; Spolaore P; Pellizzer G
J Infect; 2006 Oct; 53(4):266-73. PubMed ID: 16388852
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study.
Freundlich M; Thomsen RW; Pedersen L; West H; Schønheyder HC
J Antimicrob Chemother; 2007 Nov; 60(5):1115-23. PubMed ID: 17881632
[TBL] [Abstract][Full Text] [Related]
6. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital.
Blairon L; De Gheldre Y; Delaere B; Sonet A; Bosly A; Glupczynski Y
Clin Microbiol Infect; 2006 Jun; 12(6):527-32. PubMed ID: 16700700
[TBL] [Abstract][Full Text] [Related]
7. Magnitude of bacteraemia is a predictor of mortality during 1 year of follow-up.
Gradel KO; Søgaard M; Dethlefsen C; Nielsen H; Schønheyder HC
Epidemiol Infect; 2009 Jan; 137(1):94-101. PubMed ID: 18387214
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with mortality in bacteremic patients with hematologic malignancies.
Tumbarello M; Spanu T; Caira M; Trecarichi EM; Laurenti L; Montuori E; Fianchi L; Leone F; Fadda G; Cauda R; Pagano L
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):320-6. PubMed ID: 19345033
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
[TBL] [Abstract][Full Text] [Related]
10. Magnitude of bacteraemia is associated with increased mortality in non-typhoid salmonellosis: a one-year follow-up study.
Gradel KO; Dethlefsen C; Schønheyder HC; Nielsen H
APMIS; 2008 Feb; 116(2):147-53. PubMed ID: 18321366
[TBL] [Abstract][Full Text] [Related]
11. Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study.
Gradel KO; Thomsen RW; Lundbye-Christensen S; Nielsen H; Schønheyder HC
Clin Microbiol Infect; 2011 Apr; 17(4):627-32. PubMed ID: 20545964
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin-resistant Escherichia coli bacteraemia: relation to empiric therapy and clinical outcome.
Andersen NF; Møller J; Peterslund NA
Scand J Infect Dis; 2005; 37(2):90-5. PubMed ID: 15764199
[TBL] [Abstract][Full Text] [Related]
13. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
14. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
15. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study.
Zahar JR; Farhat H; Chachaty E; Meshaka P; Antoun S; Nitenberg G
Clin Microbiol Infect; 2005 Sep; 11(9):724-9. PubMed ID: 16104987
[TBL] [Abstract][Full Text] [Related]
17. Short-term mortality in relation to age and comorbidity in older adults with community-acquired bacteremia: a population-based cohort study.
Søgaard M; Schønheyder HC; Riis A; Sørensen HT; Nørgaard M
J Am Geriatr Soc; 2008 Sep; 56(9):1593-600. PubMed ID: 18691276
[TBL] [Abstract][Full Text] [Related]
18. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study.
Linderoth G; Jepsen P; Schønheyder HC; Johnsen SP; Sørensen HT
Alcohol Clin Exp Res; 2006 Apr; 30(4):636-41. PubMed ID: 16573581
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
[TBL] [Abstract][Full Text] [Related]
20. Statin use and mortality within 180 days after bacteremia: a population-based cohort study.
Thomsen RW; Hundborg HH; Johnsen SP; Pedersen L; Sørensen HT; Schønheyder HC; Lervang HH
Crit Care Med; 2006 Apr; 34(4):1080-6. PubMed ID: 16484926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
